Indication
Malignant Retroperitoneal Neoplasm
2 clinical trials
2 products
1 drug
Clinical trial
Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic CancersStatus: Active (not recruiting), Estimated PCD: 2025-04-30
Drug
T-VECClinical trial
A Phase 1B Trial of Preoperative Eribulin and Radiation for Retroperitoneal LiposarcomaStatus: Active (not recruiting), Estimated PCD: 2023-02-14
Product
EribulinProduct
Ipilimumab